Drugs / DTGM fusion protein
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00003840 | Oct 2000 → Sep 2002 | leukemia | Wake Forest University Health Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTGM fusion protein | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00003840 ↗ |
| Modality | Protein / enzyme biologic | “DTGM fusion protein” NCT00003840 ↗ |
| Route | Intravenous | “Patients receive DTGM fusion protein IV over 15 minutes on days 1-5.” NCT00003840 ↗ |